How to buy Chembio Diagnostics stock (CEMI)

Chembio Diagnostics is a diagnostics & research business based in the US. Chembio Diagnostics shares (CEMI) are listed on the NASDAQ and all prices are listed in US Dollars. Chembio Diagnostics employs 188 staff and has a trailing 12-month revenue of around $49.5 million.

Our top picks for where to buy Chembio Diagnostics stock

Buy Chembio Diagnostics stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Chembio Diagnostics stock price (NASDAQ: CEMI)

Use our graph to track the performance of CEMI stocks over time.

Chembio Diagnostics shares at a glance

• Key figures

Information last updated 2023-06-18.

52-week range	$0.00 - $0.00
50-day moving average more info button	$0.43
200-day moving average more info button	$0.44
Wall St. target price	$8.00
PE ratio more info button	N/A
Dividend yield more info button	$0 (0%)
Earnings per share (TTM) more info button	$-0.72

Is it a good time to buy Chembio Diagnostics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Chembio Diagnostics financials

Revenue TTM	$49.5 million
Gross profit TTM	$3.9 million
Return on assets TTM	-18.77%
Return on equity TTM	-89.47%
Profit margin	-47.03%
Book value	$0.49
Market Capitalization more info button	$16.7 million

TTM: trailing 12 months

Chembio Diagnostics share dividends

We're not expecting Chembio Diagnostics to pay a dividend over the next 12 months.

Have Chembio Diagnostics's shares ever split?

Chembio Diagnostics's shares were split on a 1:8 basis on 29 May 2012 . So if you had owned 8 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Chembio Diagnostics shares – just the quantity. However, indirectly, the new 700% higher share price could have impacted the market appetite for Chembio Diagnostics shares which in turn could have impacted Chembio Diagnostics's share price.

Chembio Diagnostics share price volatility

Over the last 12 months, Chembio Diagnostics's shares have ranged in value from as little as $0 up to $0. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Chembio Diagnostics's is 1.8571. This would suggest that Chembio Diagnostics's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Chembio Diagnostics overview

Chembio Diagnostics, Inc. , together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID 19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, lassa, marburg, leptospirosis, rickettsia, and Burkholderia diseases. The company sells its products under the STAT-PAK, SURE CHECK, STAT VIEW, NEXT GENERATION DPP, and DPP trademarks, as well as sells its products directly through distributors to medical laboratories and hospitals, governmental and public health entities, non-governmental organizations, medical professionals, and retail establishments in the United States and internationally. It has collaboration agreements with Bill & Melinda Gates Foundation, The Paul G. Allen Family Foundation, The Oswaldo Cruz Foundation, and the Foundation for Innovative New Diagnostics, as well as U.

Frequently asked questions

null
What percentage of Chembio Diagnostics is owned by insiders or institutions?
Currently 2.389% of Chembio Diagnostics shares are held by insiders and 21.67% by institutions. How many people work for Chembio Diagnostics?
Latest data suggests 188 work at Chembio Diagnostics. When does the fiscal year end for Chembio Diagnostics?
Chembio Diagnostics's fiscal year ends in December. Where is Chembio Diagnostics based?
Chembio Diagnostics's address is: 555 Wireless Boulevard, Hauppauge, NY, United States, 11788 What is Chembio Diagnostics's ISIN number?
Chembio Diagnostics's international securities identification number is: US1635722093 What is Chembio Diagnostics's CUSIP number?
Chembio Diagnostics's Committee on Uniform Securities Identification Procedures number is: 163572209